Soluble TNF receptors partially protect injured motoneurons in the postnatal CNS

There is accumulating evidence that cytokines are involved in the functioning of the brain and the spinal cord. However, it has been controversial whether they exert a neurotoxic or a neuroprotective effect. To address this question in vivo, we have examined the survival of injured motoneurons in a line of transgenic mice that overexpress the soluble form of tumour necrosis factor receptor‐1 (sTNFR1). In these animals, all of the circulating TNF and lymphotoxin‐α are neutralized by the continuous expression of the soluble receptor. Following axotomy of the facial nerve in 7‐day‐old control mice, we observed a loss of approximately 90% of the motoneurons at two weeks survival. In the transgenic mice under the same conditions, the percentage of motoneuron survival was increased two‐fold (515 vs. 224) and varied as a function of the level of the circulating receptor. These results indicate that neutralization of endogenous TNF and lymphotoxin‐α by means of overexpression of the soluble receptor can decrease cell death of injured motoneurons and suggest that these cytokines may play an important role in neuronal degeneration in the CNS following a lesion.

[1]  B. Pettmann,et al.  Programmed Cell Death of Embryonic Motoneurons Triggered through the FAS Death Receptor , 1999, The Journal of cell biology.

[2]  J Q Trojanowski,et al.  Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Guo-Yuan Yang,et al.  Cellular localization of tumor necrosis factor alpha following focal cerebral ischemia in mice , 1998, Brain Research.

[4]  H. Neumann,et al.  Immune Surveillance in the Injured Nervous System: T-Lymphocytes Invade the Axotomized Mouse Facial Motor Nucleus and Aggregate around Sites of Neuronal Degeneration , 1998, The Journal of Neuroscience.

[5]  Kevin J. Tracey,et al.  Expression of TNF and TNF Receptors (p55 and p75) in the Rat Brain after Focal Cerebral Ischemia , 1997, Molecular medicine.

[6]  R. Rizzoli,et al.  Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. , 1997, The Journal of clinical investigation.

[7]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[8]  M. Mattson,et al.  Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors , 1996, Nature Medicine.

[9]  Y. Belkaid,et al.  Transgenic mice expressing high levels of soluble TNF‐R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections , 1995, European journal of immunology.

[10]  C. Marquette,et al.  Tumor necrosis factor-alpha: specific binding sites in rodent brain and pituitary gland. , 1993, European cytokine network.

[11]  W. Snider,et al.  Axotomy-induced neuronal death during development. , 1992, Journal of neurobiology.

[12]  G. Pasternak,et al.  Identification and characterization of receptors for tumor necrosis factor-α in the brain , 1991 .

[13]  J. Dempsey Sleep apnea causes daytime hypertension. , 1997, The Journal of clinical investigation.